Global Natural Killer Cells Therapeutics Market Growth (Status and Outlook) 2025-2031

September 2025 | 82 pages | ID: GF7E0DC6C8AEN
LP Information

Abstracts

According to this study, the global Natural Killer Cells Therapeutics market size will reach US$ 442 million by 2031.

Cell therapy, a new therapeutic approach that uses a patient's own immune cells to attack tumors, has emerged as one of the most promising breakthroughs in cancer treatment. NK cells are the body's first line of defense against infections and diseases with an innate ability to rapidly seek and destroy abnormal cells.

The Americas natural killer cells therapeutics market share accounted for the highest share 52.3% in 2019.

Based on application, the market is classified into cancer, gastrointestinal diseases and others. The cancer segment accounted for a major share in 2019 (66.99%).

Major players operating in the market include Nektar Therapeutics, Innate Pharma SA, Affimed, Chipscreen Biosciences, Fate Therapeutics, Glycostem Therapeutics, Dragonfly Therapeutics, Kiadis Pharma, NantWorks, Nkarta Therapeutics and etc. The Top 6 players accounted for 96.66% of the global revenue market share in 2019.

LPI (LP Information)' newest research report, the “Natural Killer Cells Therapeutics Industry Forecast” looks at past sales and reviews total world Natural Killer Cells Therapeutics sales in 2024, providing a comprehensive analysis by region and market sector of projected Natural Killer Cells Therapeutics sales for 2025 through 2031. With Natural Killer Cells Therapeutics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Natural Killer Cells Therapeutics industry.

This Insight Report provides a comprehensive analysis of the global Natural Killer Cells Therapeutics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Natural Killer Cells Therapeutics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Natural Killer Cells Therapeutics market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Natural Killer Cells Therapeutics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Natural Killer Cells Therapeutics.

This report presents a comprehensive overview, market shares, and growth opportunities of Natural Killer Cells Therapeutics market by product type, application, key players and key regions and countries.

Segmentation by Type:

• NK Cell Therapies
• NK Cell Directed Antibodies

Segmentation by Application:

• Research Centers & Institutes
• Hospitals
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Affimed
• Celgene Corporation
• Fate Therapeutics
• Fortress Biotech
• Glycostem Therapeutics
• Innate Pharma
• Nantkwest
• Nkarta Therapeutics
• NKT Therapeutics
• Ziopharm Oncology

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Natural Killer Cells Therapeutics Market Size (2020-2031)
  2.1.2 Natural Killer Cells Therapeutics Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Natural Killer Cells Therapeutics by Country/Region (2020, 2024 & 2031)
2.2 Natural Killer Cells Therapeutics Segment by Type
  2.2.1 NK Cell Therapies
  2.2.2 NK Cell Directed Antibodies
2.3 Natural Killer Cells Therapeutics Market Size by Type
  2.3.1 Natural Killer Cells Therapeutics Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Natural Killer Cells Therapeutics Market Size Market Share by Type (2020-2025)
2.4 Natural Killer Cells Therapeutics Segment by Application
  2.4.1 Research Centers & Institutes
  2.4.2 Hospitals
  2.4.3 Others
2.5 Natural Killer Cells Therapeutics Market Size by Application
  2.5.1 Natural Killer Cells Therapeutics Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Natural Killer Cells Therapeutics Market Size Market Share by Application (2020-2025)

3 NATURAL KILLER CELLS THERAPEUTICS MARKET SIZE BY PLAYER

3.1 Natural Killer Cells Therapeutics Market Size Market Share by Player
  3.1.1 Global Natural Killer Cells Therapeutics Revenue by Player (2020-2025)
  3.1.2 Global Natural Killer Cells Therapeutics Revenue Market Share by Player (2020-2025)
3.2 Global Natural Killer Cells Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 NATURAL KILLER CELLS THERAPEUTICS BY REGION

4.1 Natural Killer Cells Therapeutics Market Size by Region (2020-2025)
4.2 Global Natural Killer Cells Therapeutics Annual Revenue by Country/Region (2020-2025)
4.3 Americas Natural Killer Cells Therapeutics Market Size Growth (2020-2025)
4.4 APAC Natural Killer Cells Therapeutics Market Size Growth (2020-2025)
4.5 Europe Natural Killer Cells Therapeutics Market Size Growth (2020-2025)
4.6 Middle East & Africa Natural Killer Cells Therapeutics Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Natural Killer Cells Therapeutics Market Size by Country (2020-2025)
5.2 Americas Natural Killer Cells Therapeutics Market Size by Type (2020-2025)
5.3 Americas Natural Killer Cells Therapeutics Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Natural Killer Cells Therapeutics Market Size by Region (2020-2025)
6.2 APAC Natural Killer Cells Therapeutics Market Size by Type (2020-2025)
6.3 APAC Natural Killer Cells Therapeutics Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Natural Killer Cells Therapeutics Market Size by Country (2020-2025)
7.2 Europe Natural Killer Cells Therapeutics Market Size by Type (2020-2025)
7.3 Europe Natural Killer Cells Therapeutics Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Natural Killer Cells Therapeutics by Region (2020-2025)
8.2 Middle East & Africa Natural Killer Cells Therapeutics Market Size by Type (2020-2025)
8.3 Middle East & Africa Natural Killer Cells Therapeutics Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL NATURAL KILLER CELLS THERAPEUTICS MARKET FORECAST

10.1 Global Natural Killer Cells Therapeutics Forecast by Region (2026-2031)
  10.1.1 Global Natural Killer Cells Therapeutics Forecast by Region (2026-2031)
  10.1.2 Americas Natural Killer Cells Therapeutics Forecast
  10.1.3 APAC Natural Killer Cells Therapeutics Forecast
  10.1.4 Europe Natural Killer Cells Therapeutics Forecast
  10.1.5 Middle East & Africa Natural Killer Cells Therapeutics Forecast
10.2 Americas Natural Killer Cells Therapeutics Forecast by Country (2026-2031)
  10.2.1 United States Market Natural Killer Cells Therapeutics Forecast
  10.2.2 Canada Market Natural Killer Cells Therapeutics Forecast
  10.2.3 Mexico Market Natural Killer Cells Therapeutics Forecast
  10.2.4 Brazil Market Natural Killer Cells Therapeutics Forecast
10.3 APAC Natural Killer Cells Therapeutics Forecast by Region (2026-2031)
  10.3.1 China Natural Killer Cells Therapeutics Market Forecast
  10.3.2 Japan Market Natural Killer Cells Therapeutics Forecast
  10.3.3 Korea Market Natural Killer Cells Therapeutics Forecast
  10.3.4 Southeast Asia Market Natural Killer Cells Therapeutics Forecast
  10.3.5 India Market Natural Killer Cells Therapeutics Forecast
  10.3.6 Australia Market Natural Killer Cells Therapeutics Forecast
10.4 Europe Natural Killer Cells Therapeutics Forecast by Country (2026-2031)
  10.4.1 Germany Market Natural Killer Cells Therapeutics Forecast
  10.4.2 France Market Natural Killer Cells Therapeutics Forecast
  10.4.3 UK Market Natural Killer Cells Therapeutics Forecast
  10.4.4 Italy Market Natural Killer Cells Therapeutics Forecast
  10.4.5 Russia Market Natural Killer Cells Therapeutics Forecast
10.5 Middle East & Africa Natural Killer Cells Therapeutics Forecast by Region (2026-2031)
  10.5.1 Egypt Market Natural Killer Cells Therapeutics Forecast
  10.5.2 South Africa Market Natural Killer Cells Therapeutics Forecast
  10.5.3 Israel Market Natural Killer Cells Therapeutics Forecast
  10.5.4 Turkey Market Natural Killer Cells Therapeutics Forecast
10.6 Global Natural Killer Cells Therapeutics Forecast by Type (2026-2031)
10.7 Global Natural Killer Cells Therapeutics Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Natural Killer Cells Therapeutics Forecast

11 KEY PLAYERS ANALYSIS

11.1 Affimed
  11.1.1 Affimed Company Information
  11.1.2 Affimed Natural Killer Cells Therapeutics Product Offered
  11.1.3 Affimed Natural Killer Cells Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Affimed Main Business Overview
  11.1.5 Affimed Latest Developments
11.2 Celgene Corporation
  11.2.1 Celgene Corporation Company Information
  11.2.2 Celgene Corporation Natural Killer Cells Therapeutics Product Offered
  11.2.3 Celgene Corporation Natural Killer Cells Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Celgene Corporation Main Business Overview
  11.2.5 Celgene Corporation Latest Developments
11.3 Fate Therapeutics
  11.3.1 Fate Therapeutics Company Information
  11.3.2 Fate Therapeutics Natural Killer Cells Therapeutics Product Offered
  11.3.3 Fate Therapeutics Natural Killer Cells Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 Fate Therapeutics Main Business Overview
  11.3.5 Fate Therapeutics Latest Developments
11.4 Fortress Biotech
  11.4.1 Fortress Biotech Company Information
  11.4.2 Fortress Biotech Natural Killer Cells Therapeutics Product Offered
  11.4.3 Fortress Biotech Natural Killer Cells Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 Fortress Biotech Main Business Overview
  11.4.5 Fortress Biotech Latest Developments
11.5 Glycostem Therapeutics
  11.5.1 Glycostem Therapeutics Company Information
  11.5.2 Glycostem Therapeutics Natural Killer Cells Therapeutics Product Offered
  11.5.3 Glycostem Therapeutics Natural Killer Cells Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Glycostem Therapeutics Main Business Overview
  11.5.5 Glycostem Therapeutics Latest Developments
11.6 Innate Pharma
  11.6.1 Innate Pharma Company Information
  11.6.2 Innate Pharma Natural Killer Cells Therapeutics Product Offered
  11.6.3 Innate Pharma Natural Killer Cells Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.6.4 Innate Pharma Main Business Overview
  11.6.5 Innate Pharma Latest Developments
11.7 Nantkwest
  11.7.1 Nantkwest Company Information
  11.7.2 Nantkwest Natural Killer Cells Therapeutics Product Offered
  11.7.3 Nantkwest Natural Killer Cells Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.7.4 Nantkwest Main Business Overview
  11.7.5 Nantkwest Latest Developments
11.8 Nkarta Therapeutics
  11.8.1 Nkarta Therapeutics Company Information
  11.8.2 Nkarta Therapeutics Natural Killer Cells Therapeutics Product Offered
  11.8.3 Nkarta Therapeutics Natural Killer Cells Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.8.4 Nkarta Therapeutics Main Business Overview
  11.8.5 Nkarta Therapeutics Latest Developments
11.9 NKT Therapeutics
  11.9.1 NKT Therapeutics Company Information
  11.9.2 NKT Therapeutics Natural Killer Cells Therapeutics Product Offered
  11.9.3 NKT Therapeutics Natural Killer Cells Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.9.4 NKT Therapeutics Main Business Overview
  11.9.5 NKT Therapeutics Latest Developments
11.10 Ziopharm Oncology
  11.10.1 Ziopharm Oncology Company Information
  11.10.2 Ziopharm Oncology Natural Killer Cells Therapeutics Product Offered
  11.10.3 Ziopharm Oncology Natural Killer Cells Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.10.4 Ziopharm Oncology Main Business Overview
  11.10.5 Ziopharm Oncology Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Natural Killer Cells Therapeutics Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Natural Killer Cells Therapeutics Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of NK Cell Therapies
Table 4. Major Players of NK Cell Directed Antibodies
Table 5. Natural Killer Cells Therapeutics Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 6. Global Natural Killer Cells Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 7. Global Natural Killer Cells Therapeutics Market Size Market Share by Type (2020-2025)
Table 8. Natural Killer Cells Therapeutics Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global Natural Killer Cells Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 10. Global Natural Killer Cells Therapeutics Market Size Market Share by Application (2020-2025)
Table 11. Global Natural Killer Cells Therapeutics Revenue by Player (2020-2025) & ($ millions)
Table 12. Global Natural Killer Cells Therapeutics Revenue Market Share by Player (2020-2025)
Table 13. Natural Killer Cells Therapeutics Key Players Head office and Products Offered
Table 14. Natural Killer Cells Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Natural Killer Cells Therapeutics Market Size by Region (2020-2025) & ($ millions)
Table 18. Global Natural Killer Cells Therapeutics Market Size Market Share by Region (2020-2025)
Table 19. Global Natural Killer Cells Therapeutics Revenue by Country/Region (2020-2025) & ($ millions)
Table 20. Global Natural Killer Cells Therapeutics Revenue Market Share by Country/Region (2020-2025)
Table 21. Americas Natural Killer Cells Therapeutics Market Size by Country (2020-2025) & ($ millions)
Table 22. Americas Natural Killer Cells Therapeutics Market Size Market Share by Country (2020-2025)
Table 23. Americas Natural Killer Cells Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 24. Americas Natural Killer Cells Therapeutics Market Size Market Share by Type (2020-2025)
Table 25. Americas Natural Killer Cells Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 26. Americas Natural Killer Cells Therapeutics Market Size Market Share by Application (2020-2025)
Table 27. APAC Natural Killer Cells Therapeutics Market Size by Region (2020-2025) & ($ millions)
Table 28. APAC Natural Killer Cells Therapeutics Market Size Market Share by Region (2020-2025)
Table 29. APAC Natural Killer Cells Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 30. APAC Natural Killer Cells Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 31. Europe Natural Killer Cells Therapeutics Market Size by Country (2020-2025) & ($ millions)
Table 32. Europe Natural Killer Cells Therapeutics Market Size Market Share by Country (2020-2025)
Table 33. Europe Natural Killer Cells Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 34. Europe Natural Killer Cells Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 35. Middle East & Africa Natural Killer Cells Therapeutics Market Size by Region (2020-2025) & ($ millions)
Table 36. Middle East & Africa Natural Killer Cells Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 37. Middle East & Africa Natural Killer Cells Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Natural Killer Cells Therapeutics
Table 39. Key Market Challenges & Risks of Natural Killer Cells Therapeutics
Table 40. Key Industry Trends of Natural Killer Cells Therapeutics
Table 41. Global Natural Killer Cells Therapeutics Market Size Forecast by Region (2026-2031) & ($ millions)
Table 42. Global Natural Killer Cells Therapeutics Market Size Market Share Forecast by Region (2026-2031)
Table 43. Global Natural Killer Cells Therapeutics Market Size Forecast by Type (2026-2031) & ($ millions)
Table 44. Global Natural Killer Cells Therapeutics Market Size Forecast by Application (2026-2031) & ($ millions)
Table 45. Affimed Details, Company Type, Natural Killer Cells Therapeutics Area Served and Its Competitors
Table 46. Affimed Natural Killer Cells Therapeutics Product Offered
Table 47. Affimed Natural Killer Cells Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 48. Affimed Main Business
Table 49. Affimed Latest Developments
Table 50. Celgene Corporation Details, Company Type, Natural Killer Cells Therapeutics Area Served and Its Competitors
Table 51. Celgene Corporation Natural Killer Cells Therapeutics Product Offered
Table 52. Celgene Corporation Natural Killer Cells Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 53. Celgene Corporation Main Business
Table 54. Celgene Corporation Latest Developments
Table 55. Fate Therapeutics Details, Company Type, Natural Killer Cells Therapeutics Area Served and Its Competitors
Table 56. Fate Therapeutics Natural Killer Cells Therapeutics Product Offered
Table 57. Fate Therapeutics Natural Killer Cells Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 58. Fate Therapeutics Main Business
Table 59. Fate Therapeutics Latest Developments
Table 60. Fortress Biotech Details, Company Type, Natural Killer Cells Therapeutics Area Served and Its Competitors
Table 61. Fortress Biotech Natural Killer Cells Therapeutics Product Offered
Table 62. Fortress Biotech Natural Killer Cells Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 63. Fortress Biotech Main Business
Table 64. Fortress Biotech Latest Developments
Table 65. Glycostem Therapeutics Details, Company Type, Natural Killer Cells Therapeutics Area Served and Its Competitors
Table 66. Glycostem Therapeutics Natural Killer Cells Therapeutics Product Offered
Table 67. Glycostem Therapeutics Natural Killer Cells Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 68. Glycostem Therapeutics Main Business
Table 69. Glycostem Therapeutics Latest Developments
Table 70. Innate Pharma Details, Company Type, Natural Killer Cells Therapeutics Area Served and Its Competitors
Table 71. Innate Pharma Natural Killer Cells Therapeutics Product Offered
Table 72. Innate Pharma Natural Killer Cells Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 73. Innate Pharma Main Business
Table 74. Innate Pharma Latest Developments
Table 75. Nantkwest Details, Company Type, Natural Killer Cells Therapeutics Area Served and Its Competitors
Table 76. Nantkwest Natural Killer Cells Therapeutics Product Offered
Table 77. Nantkwest Natural Killer Cells Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 78. Nantkwest Main Business
Table 79. Nantkwest Latest Developments
Table 80. Nkarta Therapeutics Details, Company Type, Natural Killer Cells Therapeutics Area Served and Its Competitors
Table 81. Nkarta Therapeutics Natural Killer Cells Therapeutics Product Offered
Table 82. Nkarta Therapeutics Natural Killer Cells Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 83. Nkarta Therapeutics Main Business
Table 84. Nkarta Therapeutics Latest Developments
Table 85. NKT Therapeutics Details, Company Type, Natural Killer Cells Therapeutics Area Served and Its Competitors
Table 86. NKT Therapeutics Natural Killer Cells Therapeutics Product Offered
Table 87. NKT Therapeutics Natural Killer Cells Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 88. NKT Therapeutics Main Business
Table 89. NKT Therapeutics Latest Developments
Table 90. Ziopharm Oncology Details, Company Type, Natural Killer Cells Therapeutics Area Served and Its Competitors
Table 91. Ziopharm Oncology Natural Killer Cells Therapeutics Product Offered
Table 92. Ziopharm Oncology Natural Killer Cells Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 93. Ziopharm Oncology Main Business
Table 94. Ziopharm Oncology Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Natural Killer Cells Therapeutics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Natural Killer Cells Therapeutics Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Natural Killer Cells Therapeutics Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Natural Killer Cells Therapeutics Sales Market Share by Country/Region (2024)
Figure 8. Natural Killer Cells Therapeutics Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Natural Killer Cells Therapeutics Market Size Market Share by Type in 2024
Figure 10. Natural Killer Cells Therapeutics in Research Centers & Institutes
Figure 11. Global Natural Killer Cells Therapeutics Market: Research Centers & Institutes (2020-2025) & ($ millions)
Figure 12. Natural Killer Cells Therapeutics in Hospitals
Figure 13. Global Natural Killer Cells Therapeutics Market: Hospitals (2020-2025) & ($ millions)
Figure 14. Natural Killer Cells Therapeutics in Others
Figure 15. Global Natural Killer Cells Therapeutics Market: Others (2020-2025) & ($ millions)
Figure 16. Global Natural Killer Cells Therapeutics Market Size Market Share by Application in 2024
Figure 17. Global Natural Killer Cells Therapeutics Revenue Market Share by Player in 2024
Figure 18. Global Natural Killer Cells Therapeutics Market Size Market Share by Region (2020-2025)
Figure 19. Americas Natural Killer Cells Therapeutics Market Size 2020-2025 ($ millions)
Figure 20. APAC Natural Killer Cells Therapeutics Market Size 2020-2025 ($ millions)
Figure 21. Europe Natural Killer Cells Therapeutics Market Size 2020-2025 ($ millions)
Figure 22. Middle East & Africa Natural Killer Cells Therapeutics Market Size 2020-2025 ($ millions)
Figure 23. Americas Natural Killer Cells Therapeutics Value Market Share by Country in 2024
Figure 24. United States Natural Killer Cells Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 25. Canada Natural Killer Cells Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 26. Mexico Natural Killer Cells Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 27. Brazil Natural Killer Cells Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 28. APAC Natural Killer Cells Therapeutics Market Size Market Share by Region in 2024
Figure 29. APAC Natural Killer Cells Therapeutics Market Size Market Share by Type (2020-2025)
Figure 30. APAC Natural Killer Cells Therapeutics Market Size Market Share by Application (2020-2025)
Figure 31. China Natural Killer Cells Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 32. Japan Natural Killer Cells Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 33. South Korea Natural Killer Cells Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 34. Southeast Asia Natural Killer Cells Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 35. India Natural Killer Cells Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 36. Australia Natural Killer Cells Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 37. Europe Natural Killer Cells Therapeutics Market Size Market Share by Country in 2024
Figure 38. Europe Natural Killer Cells Therapeutics Market Size Market Share by Type (2020-2025)
Figure 39. Europe Natural Killer Cells Therapeutics Market Size Market Share by Application (2020-2025)
Figure 40. Germany Natural Killer Cells Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 41. France Natural Killer Cells Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 42. UK Natural Killer Cells Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 43. Italy Natural Killer Cells Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 44. Russia Natural Killer Cells Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 45. Middle East & Africa Natural Killer Cells Therapeutics Market Size Market Share by Region (2020-2025)
Figure 46. Middle East & Africa Natural Killer Cells Therapeutics Market Size Market Share by Type (2020-2025)
Figure 47. Middle East & Africa Natural Killer Cells Therapeutics Market Size Market Share by Application (2020-2025)
Figure 48. Egypt Natural Killer Cells Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 49. South Africa Natural Killer Cells Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 50. Israel Natural Killer Cells Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 51. Turkey Natural Killer Cells Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 52. GCC Countries Natural Killer Cells Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 53. Americas Natural Killer Cells Therapeutics Market Size 2026-2031 ($ millions)
Figure 54. APAC Natural Killer Cells Therapeutics Market Size 2026-2031 ($ millions)
Figure 55. Europe Natural Killer Cells Therapeutics Market Size 2026-2031 ($ millions)
Figure 56. Middle East & Africa Natural Killer Cells Therapeutics Market Size 2026-2031 ($ millions)
Figure 57. United States Natural Killer Cells Therapeutics Market Size 2026-2031 ($ millions)
Figure 58. Canada Natural Killer Cells Therapeutics Market Size 2026-2031 ($ millions)
Figure 59. Mexico Natural Killer Cells Therapeutics Market Size 2026-2031 ($ millions)
Figure 60. Brazil Natural Killer Cells Therapeutics Market Size 2026-2031 ($ millions)
Figure 61. China Natural Killer Cells Therapeutics Market Size 2026-2031 ($ millions)
Figure 62. Japan Natural Killer Cells Therapeutics Market Size 2026-2031 ($ millions)
Figure 63. Korea Natural Killer Cells Therapeutics Market Size 2026-2031 ($ millions)
Figure 64. Southeast Asia Natural Killer Cells Therapeutics Market Size 2026-2031 ($ millions)
Figure 65. India Natural Killer Cells Therapeutics Market Size 2026-2031 ($ millions)
Figure 66. Australia Natural Killer Cells Therapeutics Market Size 2026-2031 ($ millions)
Figure 67. Germany Natural Killer Cells Therapeutics Market Size 2026-2031 ($ millions)
Figure 68. France Natural Killer Cells Therapeutics Market Size 2026-2031 ($ millions)
Figure 69. UK Natural Killer Cells Therapeutics Market Size 2026-2031 ($ millions)
Figure 70. Italy Natural Killer Cells Therapeutics Market Size 2026-2031 ($ millions)
Figure 71. Russia Natural Killer Cells Therapeutics Market Size 2026-2031 ($ millions)
Figure 72. Egypt Natural Killer Cells Therapeutics Market Size 2026-2031 ($ millions)
Figure 73. South Africa Natural Killer Cells Therapeutics Market Size 2026-2031 ($ millions)
Figure 74. Israel Natural Killer Cells Therapeutics Market Size 2026-2031 ($ millions)
Figure 75. Turkey Natural Killer Cells Therapeutics Market Size 2026-2031 ($ millions)
Figure 76. Global Natural Killer Cells Therapeutics Market Size Market Share Forecast by Type (2026-2031)
Figure 77. Global Natural Killer Cells Therapeutics Market Size Market Share Forecast by Application (2026-2031)
Figure 78. GCC Countries Natural Killer Cells Therapeutics Market Size 2026-2031 ($ millions)